Alison Ehrlich

2.1k total citations
61 papers, 1.3k citations indexed

About

Alison Ehrlich is a scholar working on Dermatology, Immunology and Immunology and Allergy. According to data from OpenAlex, Alison Ehrlich has authored 61 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Dermatology, 13 papers in Immunology and 11 papers in Immunology and Allergy. Recurrent topics in Alison Ehrlich's work include Contact Dermatitis and Allergies (23 papers), Dermatology and Skin Diseases (10 papers) and Allergic Rhinitis and Sensitization (9 papers). Alison Ehrlich is often cited by papers focused on Contact Dermatitis and Allergies (23 papers), Dermatology and Skin Diseases (10 papers) and Allergic Rhinitis and Sensitization (9 papers). Alison Ehrlich collaborates with scholars based in United States, Canada and India. Alison Ehrlich's co-authors include Mónica Rengifo‐Pardo, Olabola Awosika, D. Belsito, R A Schwartz, Maria L. Turner, Azam Qureshi, Andrew Blauvelt, Nehal N. Mehta, Aditya A. Joshi and Heather Teague and has published in prestigious journals such as Biophysical Journal, Arteriosclerosis Thrombosis and Vascular Biology and International Journal of Obesity.

In The Last Decade

Alison Ehrlich

60 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison Ehrlich United States 20 604 328 219 143 126 61 1.3k
Serafinella Patrizia Cannavò Italy 24 756 1.3× 395 1.2× 238 1.1× 190 1.3× 123 1.0× 91 1.6k
Gillian Marshman Australia 17 437 0.7× 260 0.8× 144 0.7× 80 0.6× 98 0.8× 45 917
Hirohiko Sueki Japan 20 596 1.0× 260 0.8× 175 0.8× 271 1.9× 50 0.4× 88 1.4k
Ricardo Ruíz‐Villaverde Spain 19 835 1.4× 468 1.4× 213 1.0× 245 1.7× 95 0.8× 390 1.6k
Dipankar De India 20 695 1.2× 185 0.6× 260 1.2× 194 1.4× 157 1.2× 177 1.6k
Tânia Ferreira Cestari Brazil 28 1.4k 2.3× 260 0.8× 302 1.4× 85 0.6× 88 0.7× 105 2.2k
J.‐L. Schmutz France 18 450 0.7× 184 0.6× 223 1.0× 201 1.4× 55 0.4× 163 1.2k
Ken Washenik United States 19 684 1.1× 196 0.6× 184 0.8× 80 0.6× 119 0.9× 24 1.5k
Jenny E. Murase United States 22 763 1.3× 419 1.3× 251 1.1× 191 1.3× 355 2.8× 109 1.6k
Dominique Tennstedt Belgium 21 737 1.2× 113 0.3× 189 0.9× 150 1.0× 186 1.5× 105 1.4k

Countries citing papers authored by Alison Ehrlich

Since Specialization
Citations

This map shows the geographic impact of Alison Ehrlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Ehrlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Ehrlich more than expected).

Fields of papers citing papers by Alison Ehrlich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Ehrlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Ehrlich. The network helps show where Alison Ehrlich may publish in the future.

Co-authorship network of co-authors of Alison Ehrlich

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Ehrlich. A scholar is included among the top collaborators of Alison Ehrlich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Ehrlich. Alison Ehrlich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Curiel, Rodolfo, William Nguyen, Gulnara Mamyrova, et al.. (2023). Improvement in Disease Activity in Refractory Juvenile Dermatomyositis Following Abatacept Therapy. Arthritis & Rheumatology. 75(7). 1229–1237. 14 indexed citations
2.
Kim, Hanna, Shajia Lu, Wanxia Li Tsai, et al.. (2023). Efficacy of topical ruxolitinib for cutaneous dermatomyositis. JAAD Case Reports. 45. 24–26. 2 indexed citations
3.
Ehrlich, Alison, et al.. (2023). Quaternary Ammonium Compounds and Contact Dermatitis: A Review and Considerations During the COVID-19 Pandemic. Clinical Cosmetic and Investigational Dermatology. Volume 16. 1721–1728. 14 indexed citations
4.
Awosika, Olabola, Azam Qureshi, Alison Ehrlich, & Luz Fonacier. (2018). “Chronic Urticaria”: Recommendations from an Allergist and Immunologist. Dermatitis. 29(5). 292–293. 3 indexed citations
5.
Awosika, Olabola, et al.. (2017). Understanding State Regulation of Biosimilars and Effect on Prescribers.. PubMed. 16(10). 995–1000. 1 indexed citations
6.
Rengifo‐Pardo, Mónica, et al.. (2017). A Survey Assessment of US Dermatologists' Perception of Biosimilars.. PubMed. 16(6). 612–615. 15 indexed citations
7.
Awosika, Olabola, et al.. (2017). Patient Awareness of Local Drug Price Variation and the Factors That Influence Pharmacy Choice: A Cross-sectional Survey Study. PubMed. 16(12). 1274–1280. 5 indexed citations
8.
Awosika, Olabola, et al.. (2017). A case of eosinophilic annular erythema as a presenting sign for autoimmune hepatitis. JAAD Case Reports. 4(1). 84–86. 5 indexed citations
9.
Awosika, Olabola, Stephanie Kao, Mónica Rengifo‐Pardo, & Alison Ehrlich. (2017). Angioedema, Stomatitis, and Urticaria Caused by Contact Allergy to Invisalign. Dermatitis. 28(5). 323–324. 6 indexed citations
10.
Friedenberg, Frank K., et al.. (2017). Abdominal diameter index is a stronger predictor of prevalent Barrett's esophagus than BMI or waist-to-hip ratio. Diseases of the Esophagus. 30(9). 1–6. 9 indexed citations
11.
Schalock, Peter C., Susan Nedorost, Pamela L. Scheinman, et al.. (2016). Patch Testing for Evaluation of Hypersensitivity to Implanted Metal Devices: A Perspective from the American Contact Dermatitis Society. Dermatitis. 27(5). 241–247. 51 indexed citations
12.
Rengifo‐Pardo, Mónica, et al.. (2016). Insurance Coverage of Biologics for Moderate-to-Severe Psoriasis: A Retrospective, Observational 5-Year Chart Review. American Journal of Clinical Dermatology. 17(4). 421–424. 11 indexed citations
13.
Ehrlich, Alison, et al.. (2012). Sesquiterpene Lactone–Related Allergic Contact Dermatitis After Exposure to Tulip Poplar Wood and Bark. Dermatitis. 23(2). 89–90. 3 indexed citations
14.
Ehrlich, Alison, et al.. (2011). Contact Dermatitis in the United States: Epidemiology, Economic Impact, and Workplace Prevention. Dermatologic Clinics. 30(1). 87–98. 50 indexed citations
15.
Ehrlich, Alison, et al.. (2010). Allergic Contact Dermatitis from Epoxy Resin in Solder Mask Coating in an Individual Working with Printed Circuit Boards. Dermatitis. 21(5). 288–291. 3 indexed citations
16.
Ehrlich, Alison, Bijal Amin, David J. Liewehr, et al.. (2006). Development and reliability testing of a standardized questionnaire to assess psoriasis phenotype. Journal of the American Academy of Dermatology. 54(6). 987.e1–987.e14. 9 indexed citations
17.
Nadiminti, Hari, Alison Ehrlich, & Mark C. Udey. (2005). Oral erosions as a manifestation of allergic contact sensitivity to cinnamon mints. Contact Dermatitis. 52(1). 46–47. 12 indexed citations
18.
Ehrlich, Alison, Susan Booher, Debra L. Borris, et al.. (2004). Micellar paclitaxel improves severe psoriasis in a prospective phase II pilot study. Journal of the American Academy of Dermatology. 50(4). 533–540. 49 indexed citations
19.
Ehrlich, Alison, Michael Kucenic, & D. Belsito. (2001). Role of Body Piercing in the Induction of Metal Allergies. Dermatitis. 12(3). 151–155. 8 indexed citations
20.
Ehrlich, Alison, et al.. (1984). A comparative study of ceftriaxone vs cefazolin in the treatment of cellulitis. Current Therapeutic Research. 36(4). 653–657. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Serafinella Patrizia Cannavò Breakdown of academic impact, for papers by Gillian Marshman Breakdown of academic impact, for papers by Hirohiko Sueki Breakdown of academic impact, for papers by Ricardo Ruíz‐Villaverde Breakdown of academic impact, for papers by Dipankar De Breakdown of academic impact, for papers by Tânia Ferreira Cestari Breakdown of academic impact, for papers by J.‐L. Schmutz Breakdown of academic impact, for papers by Ken Washenik Breakdown of academic impact, for papers by Jenny E. Murase Breakdown of academic impact, for papers by Dominique Tennstedt
Rankless by CCL
2026